0000000000853569

AUTHOR

David Orion

showing 1 related works from this author

Plasma myeloperoxidase levels in acute brain ischaemia and high grade carotid stenosis.

2020

Myeloperoxidase (MPO) is an important oxidative enzyme participating in different stages of cardiovascular disease and predicts prognosis. Little is known about its role in acute cerebrovascular events and carotid plaque vulnerability. In this study, the aim was to assess plasma MPO levels in acute stroke patients and their correlation to stroke severity and stroke outcome.Plasma MPO levels were assessed in patients presenting with acute brain ischaemia within 36 h of symptom onset (n = 144, mean age 64.7 ± 11.6 years, 67% men) and in patients with moderate-to-severe carotid stenosis undergoing carotid artery stenting (n = 51, mean age 66.3 ± 8.4 years, 75% men). Patients presenting with ac…

Malemedicine.medical_specialtyStroke severityDiseaseBrain Ischemia03 medical and health sciencesPlasma0302 clinical medicineModified Rankin ScaleInternal medicineIschaemic strokemedicineHumansIn patientCarotid Stenosiscardiovascular diseases030212 general & internal medicineStrokeAgedPeroxidasebiologybusiness.industryMiddle Agedmedicine.diseaseStrokeStenosisTreatment OutcomeNeurologyMyeloperoxidaseCardiologybiology.proteinFemaleNeurology (clinical)business030217 neurology & neurosurgeryEuropean journal of neurologyReferences
researchProduct